Inventor · disambiguated record
Bradford C. Sippy
Also filed as: SIPPY BRADFORD · SIPPY BRADFORD C · SIPPY BRADFORD CHARLES
20 granted patents·24 pending applications·114 citations·filing 2008–2025
94Inventor score
Files withLENNHAM PHARMACEUTICALS INC24TREMEAU PHARMACEUTICALS INC18SIPPY BRADFORD1SIPPY BRADFORD CHARLES1
Top patents by PatentIndex Score
44 records- 0198US11000534B1Deuterated derivatives of psilocybin and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2020·Granted May 11, 2021·57 cites·12 claims
- 0297US11324762B2Deuterated derivatives of psilocybin and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2021·Granted May 10, 2022·12 cites·14 claims
- 0397US10582716B1Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2019·Granted Mar 10, 2020·7 cites·23 claims
- 0496US11344564B1Method of treatment based on reduced monoamine oxidase a activityLENNHAM PHARMACEUTICALS INC·Filed 2021·Granted May 31, 2022·5 cites·22 claims
- 0596US11161833B1Deuterated etoricoxib, methods of manufacture, and use thereofTREMEAU PHARMACEUTICALS INC·Filed 2021·Granted Nov 2, 2021·4 cites·30 claims
- 0694US11547127B2Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2022·Granted Jan 10, 2023·1 cites·20 claims
- 0794US10987337B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·9 cites·28 claims
- 0894US10765130B1Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2020·Granted Sep 8, 2020·3 cites·22 claims
- 0993US11617735B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2022·Granted Apr 4, 2023·2 cites·28 claims
- 1093US11559509B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2022·Granted Jan 24, 2023·2 cites·25 claims
- 1192US10945992B1Dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2020·Granted Mar 16, 2021·6 cites·28 claims
- 1291US11576890B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·2 cites·32 claims
- 1390US11202785B1Deuterated forms of testosterone and methods of useLENNHAM PHARMACEUTICALS INC·Filed 2021·Granted Dec 21, 2021·2 cites·15 claims
- 1488US11666073B2Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·1 cites·22 claims
- 1588US11471469B2Deuterated forms of testosterone and methods of useLENNHAM PHARMACEUTICALS INC·Filed 2021·Granted Oct 18, 2022·1 cites·25 claims
- 1688US2024284942A1Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1785US2023371555A1Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1880US11872206B2Purified forms of rofecoxib, methods of manufacture and useTREMEAU PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·36 claims
- 1980US2025248424A1Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2078US2024000815A1Deuterated derivatives of psilocybin and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2177US12090159B2Deuterated forms of testosterone and methods of useLENNHAM PHARMACEUTICALS INC·Filed 2022·Granted Sep 17, 2024·0 cites·20 claims
- 2273US2020390128A1Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2373US2022409575A1Dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2471US11858909B2Deuterated etoricoxib, methods of manufacture, and use thereofTREMEAU PHARMACEUTICALS INC·Filed 2021·Granted Jan 2, 2024·0 cites·31 claims
- 2571US11633371B2Deuterated forms of acetaminophen and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2022·Granted Apr 25, 2023·0 cites·28 claims
- 2671US2022047542A1Novel dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2768US2022110955A1Deuterated derivatives of psilocybin and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2868US2021169845A1Novel dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2967US2021137878A1Novel dosage forms of rofecoxib and related methodsTREMEAU PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3067US2024409405A1Products comprising deuterium-enriched waterLENNHAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3163US2021244672A1Ingestible Product and a Method of Using the SameTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3262US2022273609A1Treatment of viral hemorrhagic fevers with etoricoxibTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3360US12194046B2D9-caffeine compositions and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2021·Granted Jan 14, 2025·0 cites·29 claims
- 3460US2023062523A1Method of treatment based on reduced monoamine oxidase a activityLENNHAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3560US2022313630A1Deuterated forms of acetaminophen and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3658US2022125773A1Aqueous formulations of water insoluble cox-2 inhibitorsTREMEAU PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3757US2020323830A1Treatment of viral hemorrhagic fevers with etoricoxibTREMEAU PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3857US2023355632A1Deuterated paraxanthine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3957US2020323813A1Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal anti-inflammatory drugsTREMEAU PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4056US2024000799A1Deuterated forms of testosterone and methods of useLENNHAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4156US2010169204A1Retail derivative financial productsSIPPY BRADFORD·Filed 2008·Application pending·0 cites
- 4255US2019083405A1Ingestible product and a method of using the sameTREMEAU PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4351US2011238561A1Pharmaceutical Derivative Financial ProductsSIPPY BRADFORD CHARLES·Filed 2011·Application pending·0 cites
- 4450US2021378266A9Deuterated caffeine and uses thereofLENNHAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bradford C. Sippy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →